Wuxi Biologics, HanchorBio Partner on Next-Gen Biologics
Wuxi Biologics and HanchorBio have announced a strategic partnership to co-develop next-generation bispecific and multi-functional fusion protein therapeutics, aiming to accelerate innovation in biologics.


